ReceptivaDx testing

What is ReceptivaDx?

This test detects inflammation of the uterine lining, most often associated with endometriosis. It can also detect recurring endometriosis in patients previously diagnosed and treated for the condition.

Endometriosis is considered one of the leading causes of unexplained infertility, IVF transfer failure and recurrent pregnancy loss.

This test can provide new answers and treatment pathways, even when genetic testing of embryos and attempts to define the best transfer window have not led to a successful pregnancy.

How it works

ReceptivaDx measures a protein called BCL6, using an endometrial biopsy.

The biopsy is collected during the window of implantation, in either a natural cycle or a controlled “mock cycle”. Accurate biopsy timing is important to the quality of the results. Your physician will confirm what is best for you.

Costs

There are two test options: ReceptivaDx with BCL6, and ReceptivaDx with BCL6 and CD138. Your care team will share current costs with you.

Results

Your results will show as positive or negative for BCL6. They come back to us within 10 to 14 business days and will be discussed at your follow-up with your physician.